Post-emergency Management of Patients With Transient Ischemic Attack
NCT ID: NCT06170034
Last Updated: 2025-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
49 participants
OBSERVATIONAL
2023-11-16
2024-06-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Because a TIA can be a "pre-alarm" for stroke in 20-30% of cases, it needs to be treated appropriately and as early as possible in the emergency department. Stroke rates after untreated TIA are 5% within 48 hours, 10% within one month and 20% within one year. This risk is calculated using the ABCD² score which is based on the patient's risk factors and the clinical manifestations of TIA. Patients with a score ≥ 3 should be hospitalized as soon as possible for a complete medical evaluation. However, this score has not been scientifically validated, and several specialists agree that all TIAs should be evaluated immediately. Preventing stroke is a major public health issue because it is a serious, disabling and sometimes fatal disease. Given the seriousness of the progression from TIA to stroke, the French National Authority for Health has issued a series of management recommendations. However, in practice, these guidelines remain complicated to follow and patients management may vary and be more or less effective.
Therefore, the aim of this study is to highlight the differences in how inpatients and outpatients are managed. Following these observations, solutions will be sought to make the care and management of these patients more efficient and more in line with recommendations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers for the Diagnosis of Transient Ischemic Attack
NCT02799511
Evaluation of the Effectiveness of a City Hospital Care Network for the Care of Patients With Transient Ischemic Accident (TIA)
NCT05216198
Life After Transient Ischemic Attack
NCT05234528
Medical Literacy in TIA (Transient Ischemic Attack) Patients
NCT07040761
Reduction of Prehospital Delays in Stroke and Transient Ischaemic Attack (TIA)
NCT00744029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TIA patients
Satisfaction questionnaire
Satisfaction questionnaire to assess how TIA patients feels about their medical care.
Medical care questionnaire
Recording appointments and results of examinations and consultations in TIA management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Satisfaction questionnaire
Satisfaction questionnaire to assess how TIA patients feels about their medical care.
Medical care questionnaire
Recording appointments and results of examinations and consultations in TIA management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consultation in the emergency department.
* Suspected TIA diagnosed by emergency physician.
* Duration of TIA symptoms \<1 hour.
Exclusion Criteria
* Patient hospitalized for a condition other than TIA, including stroke.
* Patient referred to another hospital for further examination.
* Pregnant women.
* Patient unable to understand and answer a questionnaire.
* Patient under legal protection.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Henri Duffaut - Avignon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yohan Fouilhe, Medical Intern
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier d'Avignon, Service des urgences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier d'Avignon
Avignon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEC AIT 84
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.